Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis.
Lancet Oncol
; 22(9): 1221-1229, 2021 09.
Article
in En
| MEDLINE
| ID: mdl-34363761
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Radiotherapy Dosage
/
Radiation Genomics
/
Neoplasms
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Lancet Oncol
Journal subject:
NEOPLASIAS
Year:
2021
Type:
Article
Affiliation country:
United States